Competitive Intelligence for Healthcare Tenders

Gain deep insights into competitor strategies, market dynamics, and winning patterns. Make data-driven bidding decisions backed by comprehensive tender award analysis across 10+ years of historical data, 500K+ contract awards, and 1000+ tracked competitors.

Request a Demo

Market Share Analysis - Live Example

Our platform provides detailed market share breakdowns by segment, country, and product. Example from the Germany Cardiovascular Segment (Q1 2026):

  • Teva Pharmaceuticals: 28% market share
  • Sandoz International: 24% market share
  • Mylan (Viatris): 19% market share
  • Accord Healthcare: 16% market share
  • Others: 13% market share

Track how market shares shift over time and identify opportunities for growth in specific segments.

Intelligence Capabilities

Competitor Tracking

Monitor competitor activity, winning patterns, and market positioning across all regions and therapeutic areas. Know exactly who your competitors are in each market and what they are doing.

  • Tender participation tracking — see which tenders your competitors bid on
  • Win/loss analysis by competitor — understand their success rates
  • Geographic expansion patterns — spot where competitors are entering new markets
  • Product portfolio insights — track what products competitors are tendering
  • Pricing behavior analysis — understand their pricing strategies

Market Analysis

Understand market dynamics, trends, and opportunities with comprehensive data analytics and visualization tools. Our platform processes data across all major European healthcare markets.

  • Market size and growth trends by country and therapeutic area
  • Regional market share evolution over time
  • Therapeutic area breakdown and product category analysis
  • Tender volume trends and seasonal patterns
  • Contract value distribution and pricing benchmarks

Award Intelligence

Access detailed contract award data including winners, values, and evaluation criteria to inform your strategy. Our database covers 500K+ contract awards across 30+ countries.

  • Winner identification for all major contract awards
  • Contract values, terms, and duration details
  • Award criteria analysis — understand what factors drove the decision
  • Success factor identification — learn what separates winners from losers
  • Price-to-win analysis for specific product categories

Strategic Insights

Turn data into actionable intelligence for your tender strategy.

Competitive Positioning

Understand where you stand relative to competitors and identify opportunities for market share growth. Benchmark your win rates, identify white space opportunities, and track market share evolution.

Trend Identification

Spot emerging trends early and adapt your strategy to changing market conditions. Track price trends, volume forecasting, regulatory impacts, and new market entrants.

Strategic Planning

Use intelligence insights to inform market entry strategies, product portfolio optimization, competitive response planning, and resource prioritization across markets.

Performance Analytics

Track your own performance against industry benchmarks with win rate tracking, bid success analysis, ROI measurement, and performance benchmarking across markets and products.

Comprehensive Data Coverage

Historical and real-time intelligence across all major healthcare markets.

  • 10+ Years of historical tender and award data
  • 500K+ Contract Awards analyzed and structured
  • 1000+ Tracked Competitors across all major markets
  • 30+ Countries with active coverage and monitoring

Competitive Landscape by Country

Every European market has a different competitive dynamic. RGS provides granular competitive intelligence by country, helping you understand who you are competing against and how to position your bids.

  • Germany: Track competitors across GKV discount contracts (Rabattverträge) and hospital tenders. Understand how AOK, Barmer, TK, and other insurance funds evaluate bids. Monitor competitors like Teva, Sandoz, Stada, Hexal, Ratiopharm, Mylan/Viatris, Accord, and others.
  • Italy: One of Europe's most competitive markets with high generic penetration. Track CONSIP national framework winners, regional ASL awards, and hospital-level procurement across competitors including Teva, Sandoz, Mylan, Accord, EG/Stada, DOC Generici, and local players.
  • France: Monitor hospital group (GHT) awards, UGAP frameworks, and regional tenders. Track competitive dynamics including Biogaran, Sandoz, Teva, Mylan, Arrow, EG Labo, Zentiva, and others.
  • Spain: Track tender awards across 17 autonomous communities. Monitor competitors including Cinfa, Normon, Kern Pharma, Teva, Sandoz, Stada, and Viatris in one of Europe's most price-competitive markets.
  • UK: Monitor NHS framework awards, hospital trust procurement, and NHS Supply Chain contracts. Track competitive positioning of Accord, Teva, Sandoz, Mylan, Dr. Reddy's, Aurobindo, Cipla, and others.
  • Nordics: Track Amgros (Denmark) awards, Swedish regional procurement, Norwegian Sykehusinnkjøp contracts. Monitor how Nordic markets lead in biosimilar adoption and sustainability criteria.
  • Benelux: Monitor Netherlands hospital group purchasing (Intrakoop), Belgian federal tenders, and Luxembourg procurement.
  • Central and Eastern Europe: Track growing tender volumes in Poland (largest CEE market), Czech Republic, Hungary, Romania, Bulgaria, Croatia, Slovakia, and Slovenia. These markets are increasingly attractive for generics companies seeking volume growth.

Intelligence for Different Company Types

Our competitive intelligence serves different types of healthcare companies with tailored insights:

  • Generics Manufacturers: Track competitor portfolio expansion, market entry timing, pricing strategies, and market share dynamics across your molecule portfolio. Understand which competitors are first-to-file for upcoming LoE opportunities.
  • Biosimilar Companies: Monitor originator vs. biosimilar award patterns, switching rates, interchangeability decisions, and pricing benchmarks. Track how hospital formulary committees make biosimilar decisions.
  • Originator/Innovator Pharma: Track generic and biosimilar entry patterns to defend market share. Monitor tender criteria that favor originators (quality, supply track record, clinical data). Understand how your branded products perform in value-based tendering evaluations.
  • Medical Device Manufacturers: Track competitor device procurement patterns, hospital equipment replacement cycles, and diagnostic reagent tender awards. Monitor technology adoption trends across healthcare systems.
  • API Manufacturers and CMOs/CDMOs: Understand downstream tender dynamics to optimize your supply chain positioning. Track which finished dosage form manufacturers are winning tenders and in which markets.
  • Distributors and Wholesalers: Monitor tender award patterns to optimize your product portfolio and supplier relationships. Track market access trends to identify partnership opportunities with manufacturers.

Gain Competitive Advantage

See how our competitive intelligence platform can inform your tender strategy and help you win more contracts.

Book a Demo

Net Pricing and Gross-to-Net Analysis

Understanding true net prices — not just list prices — is critical for competitive tender bidding. RGS provides net pricing intelligence derived from publicly announced tender awards, contract notices, and award documents across major markets.

  • Net Price Tracking: Calculate average unit net prices from public tender awards across 30+ countries
  • Gross-to-Net Evolution: Understand how discounts and rebates are evolving by product category and market
  • Price Erosion Analysis: Track how prices decline after Loss of Exclusivity (LoE) and generic entry across markets
  • Cross-Country Price Comparisons: Compare net pricing levels across European markets to optimize international pricing strategies and manage reference pricing risks

In an era where governments and payers compare prices across borders, pricing must be rooted in evidence. Our net pricing data gives you that evidence.

Loss of Exclusivity (LoE) Competitive Intelligence

When blockbuster drugs lose patent protection, the competitive landscape transforms rapidly. RGS tracks the entire LoE lifecycle from a competitive intelligence perspective:

  • Pre-LoE Monitoring: Track which generics companies are filing for market authorization and preparing to enter post-patent markets
  • Market Entry Tracking: Monitor the speed and scale of generic entry after patent expiry, and how many competitors enter each market
  • Price Erosion Curves: Understand typical price declines (often 80-95% within 2-3 years) by molecule, country, and competitive intensity
  • Tender Timing Intelligence: Know when procurers typically switch from branded to generic procurement and how tender structures change
  • Competitor Portfolio Monitoring: Track which companies are building their generics or biosimilar portfolios for upcoming LoE opportunities

ESG and Value-Based Tendering Intelligence

The shift from lowest-price-wins to value-based tendering is accelerating across Europe. RGS tracks how ESG (Environmental, Social, Governance) and sustainability criteria are reshaping tender evaluation:

  • ESG Criteria Tracking: Monitor which procuring authorities include sustainability requirements and how they are weighted
  • Supply Chain Transparency: Track requirements for supply chain disclosure, carbon footprint reporting, and ethical sourcing
  • Social Value Scoring: Understand how local employment, workforce development, and community impact are being evaluated
  • Environmental Requirements: Track packaging sustainability, waste reduction, and environmental management system requirements
  • Country-Specific ESG Trends: Some markets (Nordics, Netherlands) are leading ESG adoption in procurement — we track these trends early so you can prepare

Understanding ESG criteria is no longer optional — it is increasingly a decisive factor in tender award decisions across European healthcare procurement.